Third, decreased ABCA7 may contribute to AD pathology in the early stages of disease; however, it is possible that at later stages (which are measured in post-mortem brain), ABCA7 is upregulated as a compensatory mechanism in AD brains; e.g. to increase phagocytic clearance of amyloid plaques. Here, ABCA7 is linked to Alzheimer disease.